Navigation Links
Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
Date:4/9/2008

cur at any stage of testing. The Company does not know whether its Phase 3 registration trial or any future clinical trials will demonstrate safety and efficacy sufficient to result in marketable products. Favrille's failure to adequately demonstrate the safety and efficacy of Specifid will prevent the Company from obtaining regulatory approval for, or commercializing, Specifid.

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, references to Favrille's product candidates, proprietary technologies and research and clinical development programs. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Favrille's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to progress and timing of clinical trials for Specifid, including difficulties or delays in development, testing, manufacturing and marketing Specifid or Favrille's other product candidates; delays in the availability of data from Favrille's Phase 3 clinical trial; Favrille's ability to obtain marketing approval for Specifid or Favrille's other product candidates and the timing of any such approvals, including whether it will receive expedited review as a result of the Fast Track designation; Favrille's ability to manufacture sufficient quantities of Specifid for use in clinical trials and, if Specifid receives marketing approval, for commercialization; risks associated with achieving projected operating metrics and financial performance or the anticipated number of patients using Specifid; Favrille's ability to obtain additional financing to support its operations; and additional risks discussed in Favrille's filings with the Securities and Exchange Commission. In ad
'/>"/>

SOURCE Favrille, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
2. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
3. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
4. Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
5. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
6. Medarex Announces Ipilimumab Program Continues to Move Forward
7. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
8. CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors
9. ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom(TM) QD (Once-Daily) Formulation
10. CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model
11. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Equipment, Inc. for the third straight year, No. ... 500|5000, an exclusive ranking of the nation,s fastest-growing ... look at the most important segment of the ... Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, and many ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... , Aug. 21, 2014  Zacks.com announces the list of ... Equity Research analysts discuss the latest news and events impacting ... blog include the Hewlett-Packard (NYSE: HPQ - Free Report ), ... Inc. (NYSE: SB - Free Report ), GlaxoSmithKline plc ... N.V. (NYSE: FI - Free Report ). ...
Breaking Medicine Technology:Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3ScriptPro Achieves HITRUST Certification 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... Feb. 15, 2012  LodgeNet Interactive Corporation (Nasdaq: ... connectivity services to hospitality and healthcare businesses and the ... its Fourth Quarter and full year 2011 results after ... (Logo:  http://photos.prnewswire.com/prnh/20080115/AQTU120LOGO ) The Company ...
... /PRNewswire-iReach/ -- The more companies learn about ... special injection-molding technology to add value to their product lines. ... total production costs—that,s pretty rare these days. So, ... process, a thin layer of TPE (thermoplastic elastomer) is overshot ...
Cached Medicine Technology:LodgeNet Interactive to Report Fourth Quarter and Full Year 2011 Results on February 22nd 2Add Value Through Overmolding 2Add Value Through Overmolding 3
(Date:8/22/2014)... treated for the cancer Hodgkin lymphoma will be able ... researchers estimated their risk of premature menopause with different ... Journal of the National Cancer Institute , are based ... in England and Wales treated for the cancer over ... research has suggested that women with Hodgkin lymphoma who ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Human induced ... field of regenerative medicine because they can be coaxed ... don’t always act as anticipated. They sometimes mutate, develop ... in a new study recently published in STEM CELLS ... around this, simply by removing the material used to ...
(Date:8/22/2014)... Thompson HealthDay Reporter ... American health-care workers infected with the deadly Ebola virus ... been released from the Atlanta hospital where they have ... Dr. Kent Brantly, 33, was released from Emory ... hospital Tuesday. Her family said the 59-year-old woman is ...
(Date:8/22/2014)... 22, 2014 Goats are taking over Beverly ... attends the 10th annual Pre-Emmy Awards Boom Boom Room. Celebrities ... the best new products for kids on August 23 at ... and we’ll be encouraging them to #GoGoat for L.A. families ... to present our gentle, non-GMO goat milk foods to health-conscious ...
(Date:8/22/2014)... 2014 Being optimistic about the ... some foreign and domestic companies are speeding up ... and acquisitions. In 2012, Medtronic, Inc. acquired the ... Kanghui Holdings for USD 816 million; In Jan. ... makers-- Trauson Holdings Company Limited for HKD5.9 billion; ...
Breaking Medicine News(10 mins):Health News:Scientists map risk of premature menopause after cancer treatment 2Health News:Removing Programming Material After Inducing Stem Cells Could Improve Their Regeneration Ability 2Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 2Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 3Health News:#GoGoat with Kabrita at the Pre-Emmy Awards Boom Boom Room 2Health News:China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017 2
... Host Free Webcast on Making a Smooth Transition to the ... Incorporated (NYSE: IRM ), the global leader in ... share tips during an upcoming Webcast for how healthcare providers ... , In this free, hour-long Webcast, attendees will learn the ...
... researcher says , THURSDAY, June 4 (HealthDay News) -- ... the world don,t perform as well as males in math. ... the United States and abroad that appears in the June 1 ... , "There are countries where the gender disparity in math ...
... June 4 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... and services to the global life sciences markets, today ... financial results on Thursday, June 11, 2009. , The ... analysts with Stephen P. DeFalco, President and Chief Executive ...
... , , Proven Interoperability Solution Expands ... Carestream, Intergy RIS, Cloverleaf, Meditech RIS, McKesson, PowerScribe ... June 4 Healthcare IT workflow management pioneer ... its comprehensive suite of Enterprise digital imaging and ...
... plans reduce audit risk while ensuring accurate payments and compliance with ... a select few have ever wondered how to integrate Medicare Risk ... hear about the latest release from Storan Technologies Inc. ... of Merlin Medicare Risk Adjustment 6.0 (TM), a ...
... relief for pain, strengthening of immune systems and more , ... more research is showing that most illness, disease and other ... of the cellular immune system with essential nutrition. Key to ... nutrients and water. This is something that,s become more difficult ...
Cached Medicine News:Health News:Best Practices for Hospitals Moving to Electronic Medical Records 2Health News:Girls and Math: Blame the Culture, Not Ability 2Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 2Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 3Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 4Health News:St. Louis Firm Brings Medicare Risk Adjustment to iPhone 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: